Jason M Sheltzer

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Top Venues

Nature communications

Nature reviews. Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Zicheng Wang, Yunong Xia, Lauren Mills, Athanasios N Nikolakopoulos, Nicole Maeser, Scott M Dehm, Jason M Sheltzer, Ruping Sun
Evolving copy number gains promote tumor expansion and bolster mutational diversification. Nature communications 15 (1) (2024)
Zicheng Wang, Yunong Xia, Lauren Mills, Athanasios N Nikolakopoulos, Nicole Maeser, Scott M Dehm, Jason M Sheltzer, Ruping Sun
Evolving copy number gains promote tumor expansion and bolster mutational diversification. Nature communications 15 (1) (2024)
Zicheng Wang, Yunong Xia, Lauren Mills, Athanasios N Nikolakopoulos, Nicole Maeser, Scott M Dehm, Jason M Sheltzer, Ruping Sun
Evolving copy number gains promote tumor expansion and bolster mutational diversification. Nature communications 15 (1) (2024)
Leanne M Brown, Ryan A Hagenson, Tilen Koklič, Iztok Urbancic, Lu Qiao, Janez Štrancar, Jason M Sheltzer
An elevated rate of whole-genome duplications in cancers from Black patients. Nature communications 15 (1) (2024)
Guillaume Médard, Jason M Sheltzer
Ricolinostat is not a highly selective HDAC6 inhibitor. Nature cancer (2023)
Vishruth Girish, Asad A Lakhani, Sarah L Thompson, Christine M Scaduto, Leanne M Brown, Ryan A Hagenson, Erin L Sausville, Brianna E Mendelson, Pranav K Kandikuppa, Devon A Lukow, Monet Lou Yuan, Eric C Stevens, Sophia N Lee, Klaske M Schukken, Saron M Akalu, Anand Vasudevan, Charles Zou, Barbora Salovska, Wenxue Li, Joan C Smith, Alison M Taylor, Robert A Martienssen, Yansheng Liu, Ruping Sun, Jason M Sheltzer
Oncogene-like addiction to aneuploidy in human cancers. Science (New York, N.Y.) (2023)
Anand Vasudevan, Klaske M Schukken, Erin L Sausville, Vishruth Girish, Oluwadamilare A Adebambo, Jason M Sheltzer
Aneuploidy as a promoter and suppressor of malignant growth. Nature reviews. Cancer 21 (2) (2021)
Ann Lin, Christopher J Giuliano, Ann Palladino, Kristen M John, Connor Abramowicz, Monet Lou Yuan, Erin L Sausville, Devon A Lukow, Luwei Liu, Alexander R Chait, Zachary C Galluzzo, Clara Tucker, Jason M Sheltzer
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Science translational medicine 11 (509) (2020)
Ann Lin, Jason M Sheltzer
Discovering and validating cancer genetic dependencies: approaches and pitfalls. Nature reviews. Genetics 21 (11) (2020)
Maja Kneissig, Kristina Keuper, Mirjam S de Pagter, Markus J van Roosmalen, Jana Martin, Hannah Otto, Verena Passerini, Aline Campos Sparr, Ivo Renkens, Fenna Kropveld, Anand Vasudevan, Jason M Sheltzer, Wigard P Kloosterman, Zuzana Storchová
Micronuclei-based model system reveals functional consequences of chromothripsis in human cells. eLife 8 (2019)
Christopher J Giuliano, Ann Lin, Joan C Smith, Ann C Palladino, Jason M Sheltzer
MELK expression correlates with tumor mitotic activity but is not required for cancer growth. eLife 7 (2018)
Joan C Smith, Jason M Sheltzer
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis. eLife 7 (2018)
Ann Lin, Christopher J Giuliano, Nicole M Sayles, Jason M Sheltzer
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. eLife 6 (2017)